Yamada S, Ko T, Ito M, Sassa T, Nomura S, Okuma H, et al. TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy. Sci Adv. 2023;9:eade7047 pubmed publisher

Jubair L, Fallaha S, McMillan N. Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors. Mol Ther. 2019;27:2091-2099 pubmed publisher

Bosshard S, Duroy P, Mermod N. A role for alternative end-joining factors in homologous recombination and genome editing in Chinese hamster ovary cells. DNA Repair (Amst). 2019;82:102691 pubmed publisher

Nottle M, Salvaris E, Fisicaro N, McIlfatrick S, Vassiliev I, Hawthorne W, et al. Targeted insertion of an anti-CD2 monoclonal antibody transgene into the GGTA1 locus in pigs using FokI-dCas9. Sci Rep. 2017;7:8383 pubmed publisher

Pan Y, Shen N, Jung Klawitter S, Betzen C, Hoffmann G, Hoheisel J, et al. CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model. Sci Rep. 2016;6:35794 pubmed publisher

Terao M, Tamano M, Hara S, Kato T, Kinoshita M, Takada S. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9. Exp Anim. 2016;65:275-83 pubmed publisher

Hara S, Tamano M, Yamashita S, Kato T, Saito T, Sakuma T, et al. Generation of mutant mice via the CRISPR/Cas9 system using FokI-dCas9. Sci Rep. 2015;5:11221 pubmed publisher

Guilinger J, Thompson D, Liu D. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol. 2014;32:577-582 pubmed publisher